EP Patent

EP3958865B1 — 4h-pyrrolo[3,2-c]pyridin-4-one derivatives

Assigned to Bayer AG · Expires 2025-12-10 · 0y expired

What this patent protects

Patent listed against sevabertinib.

Drugs covered by this patent

sevabertinib (SEVABERTINIB)

Patent Metadata

Patent number: EP3958865B1
Jurisdiction: EP
Classification: —
Expires: 2025-12-10
Drug substance claim: No
Drug product claim: No
Assignee: Bayer AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.